DiscoveryProbe™ Anti-cancer Compound Library
Cat# L1023-100
Size : 100uL/well(10mMsolution),96WellRacksWithScrewCap
Brand : APExBIO Technology
DiscoveryProbe™ Anti-cancer Compound Library
Catalog No.
L1023
1164 anti-cancer compounds
Featured Products
- 1. Yu-qi Chen, Jun-rui Ye, et al. "Esflurbiprofen exerts a fast-onset antidepressant effect by blocking SERT-nNOS interaction." Acta Pharmacol Sin. 2025 Oct 9. PMID: 41068287
- 2. Yang Tian, Wei Li, et al. "Pharmacological Targeting of DHHC9‐Mediated STRN4 Palmitoylation to Suppress YAP‐Driven Cancer Metastasis." J Cell Mol Med. 2025 Sep;29(17):e70815. PMID: 40903842
- 3. Ying Kong, Zongming Jia, et al. "Identification of PLAC1 as a prognostic biomarker and molecular target in clear cell renal cell carcinoma." Cell Signal. 2025 Jan 13:127:111606. PMID: 39814247
- 4. Yanfei Hou, Zhimeng Wang, et al. "SMPDL3A is a cGAMP-degrading enzyme induced by LXR-mediated lipid metabolism to restrict cGAS-STING DNA sensing." Immunity. 2023 Nov 14;56(11):2492-2507. PMID: 37890481
- 5. Jing Han, Shuiqing Hu, et al. "Discovery of podofilox as a potent cGAMP–STING signaling enhancer with antitumor activity." Cancer Immunol Res. 2023 May 3;11(5):583-599. PMID: 36921097
| Catalog No. | Product Name | Summary | Targets | CAS Number | Smiles |
| A3004 | Vemurafenib (PLX4032, RG7204) | BRAF kinase inhibitor | MEK1/2 | 918504-65-1 | CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F |
| A3446 | GSK126 | EZH2 inhibitor | EZH2 | 1346574-57-9 | CCC(C)N1C=C(C2=C(C=C(C=C21)C3=CN=C(C=C3)N4CCNCC4)C(=O)NCC5=C(C=C(NC5=O)C)C)C |
| A4007 | MLN9708 | Proteasome inhibitor | Proteasome | 1201902-80-8 | B1(OC(=O)CC(O1)(CC(=O)O)C(=O)O)C(CC(C)C)NC(=O)CNC(=O)C2=C(C=CC(=C2)Cl)Cl |
| A4115 | JNJ-7706621 | Potent CDK/Aurora kinase inhibitor | Aurora Kinase | 443797-96-4 | C1=CC(=C(C(=C1)F)C(=O)N2C(=NC(=N2)NC3=CC=C(C=C3)S(=O)(=O)N)N)F |
| A5078 | KU-0063794 | MTORC1 and mTORC2 inhibitor | mTOR | 938440-64-3 | CC1CN(CC(O1)C)C2=NC3=C(C=CC(=N3)C4=CC(=C(C=C4)OC)CO)C(=N2)N5CCOCC5 |
| A8169 | Everolimus (RAD001) | MTOR inhibitor | mTOR | 159351-69-6 | OCCO[C@H]1[C@H](OC)C[C@H](C[C@H](C)[C@H](CC([C@H](C)/C=C(C)/[C@@H](O)[C@H]2OC)=O)OC([C@@H]3CCCCN3C(C([C@@]4(O)[C@H](C)CC[C@@H](C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C2=O)O4)=O)=O)=O)CC1 |
| A8323 | WP1130 | Deubiquitinase (DUB) inhibitor, Cell permeable | DUB | 856243-80-6 | CCCC(C1=CC=CC=C1)NC(=O)C(=CC2=NC(=CC=C2)Br)C#N |
| A8547 | Tubastatin A HCl | HDAC6 inhibitor,potent and selective | HDAC | 1310693-92-5 | CN1CCC2=C(C1)C3=CC=CC=C3N2CC4=CC=C(C=C4)C(=O)NO.Cl |
Related Biological Data
Related Biological Data
Related Biological Data
Related Biological Data
Related Biological Data
| Form | Pre-dissolved DMSO solutions | Stability | Solution: -20°C for 12 months, -80°C for 24 months |
| Packaging | 96-well rack with Matrix 2D Barcoded ScrewTop Storage tubes (250 μL or 100 μL/well, 10 mM DMSO). 96-well DeepWell format with peelable foil seal and EVA cap (100 μL/well, 10 mM DMSO). | ||
| Shipping Condition | Evaluation sample solution: ship with blue ice All other available size: ship with RT, or blue ice upon request | ||
-- Available in stock with overnight delivery and free shipping over $500.
-- Cost-effective and competitive price to save your budget.
-- Potent, selective and cell-permeable in inhibiting or activating target molecules.
-- Diverse in chemical structure and route of administration (oral/i.m/i.v injection etc.)
-- Detailed files describing potency, selectivity and applications etc.
-- Supported by published data from top peer-reviewed journals.
-- Guaranteed high quality with NMR and HPLC validation.
You might also be interested by the following products:
Cat#
Description
Cond.
Price Bef. VAT
